Isabel Verduyn van Weegen - 07 Nov 2025 Form 4 Insider Report for Evommune, Inc.

Reporting relationship: Director, 10%+ Owner
Issuer ticker: EVMN on NYSE
Reported as of: 07 Nov 2025
Net transaction value: +$25,000,000
SEC form: 4
Accepted by SEC: 12 Nov 2025, 16:24:08 UTC
Prior SEC filing: 05 Nov 2025
Next SEC filing: 18 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

Isabel Verduyn van Weegen filed Form 4 for Evommune, Inc. on 12 Nov 2025.

Key facts

This page summarizes Isabel Verduyn van Weegen's Form 4 filing for Evommune, Inc..
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 12 Nov 2025, 16:24.

Change

Previous filing in this sequence was filed on 05 Nov 2025.
Current net transaction value: +$25,000,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002094941 Primary reporting owner

Verduyn-van Weegen Felice Isabel

Relationship: Director, 10%+ Owner
Address: C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO
Signature: /s/ Gregory S. Moss, Attorney-in-Fact
Signature date: 12 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVMN transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +3,367,133
Change %
Price
Shares after: 3,367,133
Date: 07 Nov 2025
Ownership: By LSP 7 Cooperatief U.A.
Footnotes: F1, F2, F3, F4

EVMN transaction

Common Stock

Purchase

Transaction value: $25,000,000
Shares: +1,562,500
Change %: +46%
Price: $16.00
Shares after: 4,929,633
Date: 07 Nov 2025
Ownership: By LSP 7 Cooperatief U.A.
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVMN transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares: -15,493,466
Change %: -100%
Price
Shares after: 0
Date: 07 Nov 2025
Ownership: By LSP 7 Cooperatief U.A.
Underlying class: Common Stock
Underlying amount: 1,947,477
Exercise price
Footnotes: F1, F4

EVMN transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares: -5,090,000
Change %: -100%
Price
Shares after: 0
Date: 07 Nov 2025
Ownership: By LSP 7 Cooperatief U.A.
Underlying class: Common Stock
Underlying amount: 646,587
Exercise price
Footnotes: F2, F4

EVMN transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value
Shares: -6,585,011
Change %: -100%
Price
Shares after: 0
Date: 07 Nov 2025
Ownership: By LSP 7 Cooperatief U.A.
Underlying class: Common Stock
Underlying amount: 773,069
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each share of Series A Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-7.9557 basis and had no expiration date.

Footnote F2

Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date.

Footnote F3

Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-8.518 basis and had no expiration date.

Footnote F4

These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein.